Mononucleosis Diagnostic Market, Global Outlook and Forecast 2022-2028

April 2022 | 64 pages | ID: M5A9E95BF357EN
Market Monitor Global

Abstracts

Mononucleosis (infection) is an acute, self-limited Infectious disease caused by EBV (a contagious virus, Epstein-Barr) . The clinical features were fever, Laryngitis, Hepatosplenomegaly, abnormal blood lymphocyte, abnormal lymphocyte, positive hetero-agglutination test and anti-EBV antibody in Vivo after infection. Adolescents and young adults (12 to 40 years old) are more likely to be affected.

This report contains market size and forecasts of Mononucleosis Diagnostic in Global, including the following market information:

Global Mononucleosis Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mononucleosis Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monospot Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mononucleosis Diagnostic include Abbott Laboratories, ELITechGroup, Beckman Coulter, Bio-Rad Laboratories, Cardinal Health, Immunostics, Meridian Bioscience, Quidel Corporation and Sekisui Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mononucleosis Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mononucleosis Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mononucleosis Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Monospot Test
• Complete Blood Count Test
• Epstein Barr Virus (EBV) Antibody Test

Global Mononucleosis Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mononucleosis Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Laboratories
• Others

Global Mononucleosis Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mononucleosis Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mononucleosis Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mononucleosis Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• ELITechGroup
• Beckman Coulter
• Bio-Rad Laboratories
• Cardinal Health
• Immunostics
• Meridian Bioscience
• Quidel Corporation
• Sekisui Diagnostics
• Thermo Fischer Scientific
• Siemens
• Biomerieux

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Mononucleosis Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Mononucleosis Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MONONUCLEOSIS DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Mononucleosis Diagnostic Market Size: 2021 VS 2028
2.2 Global Mononucleosis Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Mononucleosis Diagnostic Players in Global Market
3.2 Top Global Mononucleosis Diagnostic Companies Ranked by Revenue
3.3 Global Mononucleosis Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Mononucleosis Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mononucleosis Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mononucleosis Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Mononucleosis Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Mononucleosis Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Mononucleosis Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Monospot Test
  4.1.3 Complete Blood Count Test
  4.1.4 Epstein Barr Virus (EBV) Antibody Test
4.2 By Type - Global Mononucleosis Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Mononucleosis Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Mononucleosis Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Mononucleosis Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Mononucleosis Diagnostic Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Laboratories
  5.1.4 Others
5.2 By Application - Global Mononucleosis Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Mononucleosis Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Mononucleosis Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Mononucleosis Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Mononucleosis Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Mononucleosis Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Mononucleosis Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Mononucleosis Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Mononucleosis Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Mononucleosis Diagnostic Revenue, 2017-2028
  6.3.2 US Mononucleosis Diagnostic Market Size, 2017-2028
  6.3.3 Canada Mononucleosis Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Mononucleosis Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Mononucleosis Diagnostic Revenue, 2017-2028
  6.4.2 Germany Mononucleosis Diagnostic Market Size, 2017-2028
  6.4.3 France Mononucleosis Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Mononucleosis Diagnostic Market Size, 2017-2028
  6.4.5 Italy Mononucleosis Diagnostic Market Size, 2017-2028
  6.4.6 Russia Mononucleosis Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Mononucleosis Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Mononucleosis Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Mononucleosis Diagnostic Revenue, 2017-2028
  6.5.2 China Mononucleosis Diagnostic Market Size, 2017-2028
  6.5.3 Japan Mononucleosis Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Mononucleosis Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Mononucleosis Diagnostic Market Size, 2017-2028
  6.5.6 India Mononucleosis Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Mononucleosis Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Mononucleosis Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Mononucleosis Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Mononucleosis Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Mononucleosis Diagnostic Market Size, 2017-2028
  6.7.3 Israel Mononucleosis Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Mononucleosis Diagnostic Market Size, 2017-2028
  6.7.5 UAE Mononucleosis Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Mononucleosis Diagnostic Major Product Offerings
  7.1.4 Abbott Laboratories Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 ELITechGroup
  7.2.1 ELITechGroup Corporate Summary
  7.2.2 ELITechGroup Business Overview
  7.2.3 ELITechGroup Mononucleosis Diagnostic Major Product Offerings
  7.2.4 ELITechGroup Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 ELITechGroup Key News
7.3 Beckman Coulter
  7.3.1 Beckman Coulter Corporate Summary
  7.3.2 Beckman Coulter Business Overview
  7.3.3 Beckman Coulter Mononucleosis Diagnostic Major Product Offerings
  7.3.4 Beckman Coulter Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Beckman Coulter Key News
7.4 Bio-Rad Laboratories
  7.4.1 Bio-Rad Laboratories Corporate Summary
  7.4.2 Bio-Rad Laboratories Business Overview
  7.4.3 Bio-Rad Laboratories Mononucleosis Diagnostic Major Product Offerings
  7.4.4 Bio-Rad Laboratories Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Laboratories Key News
7.5 Cardinal Health
  7.5.1 Cardinal Health Corporate Summary
  7.5.2 Cardinal Health Business Overview
  7.5.3 Cardinal Health Mononucleosis Diagnostic Major Product Offerings
  7.5.4 Cardinal Health Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Cardinal Health Key News
7.6 Immunostics
  7.6.1 Immunostics Corporate Summary
  7.6.2 Immunostics Business Overview
  7.6.3 Immunostics Mononucleosis Diagnostic Major Product Offerings
  7.6.4 Immunostics Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 Immunostics Key News
7.7 Meridian Bioscience
  7.7.1 Meridian Bioscience Corporate Summary
  7.7.2 Meridian Bioscience Business Overview
  7.7.3 Meridian Bioscience Mononucleosis Diagnostic Major Product Offerings
  7.7.4 Meridian Bioscience Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Meridian Bioscience Key News
7.8 Quidel Corporation
  7.8.1 Quidel Corporation Corporate Summary
  7.8.2 Quidel Corporation Business Overview
  7.8.3 Quidel Corporation Mononucleosis Diagnostic Major Product Offerings
  7.8.4 Quidel Corporation Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 Quidel Corporation Key News
7.9 Sekisui Diagnostics
  7.9.1 Sekisui Diagnostics Corporate Summary
  7.9.2 Sekisui Diagnostics Business Overview
  7.9.3 Sekisui Diagnostics Mononucleosis Diagnostic Major Product Offerings
  7.9.4 Sekisui Diagnostics Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 Sekisui Diagnostics Key News
7.10 Thermo Fischer Scientific
  7.10.1 Thermo Fischer Scientific Corporate Summary
  7.10.2 Thermo Fischer Scientific Business Overview
  7.10.3 Thermo Fischer Scientific Mononucleosis Diagnostic Major Product Offerings
  7.10.4 Thermo Fischer Scientific Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 Thermo Fischer Scientific Key News
7.11 Siemens
  7.11.1 Siemens Corporate Summary
  7.11.2 Siemens Business Overview
  7.11.3 Siemens Mononucleosis Diagnostic Major Product Offerings
  7.11.4 Siemens Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.11.5 Siemens Key News
7.12 Biomerieux
  7.12.1 Biomerieux Corporate Summary
  7.12.2 Biomerieux Business Overview
  7.12.3 Biomerieux Mononucleosis Diagnostic Major Product Offerings
  7.12.4 Biomerieux Mononucleosis Diagnostic Revenue in Global Market (2017-2022)
  7.12.5 Biomerieux Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Mononucleosis Diagnostic Market Opportunities & Trends in Global Market
Table 2. Mononucleosis Diagnostic Market Drivers in Global Market
Table 3. Mononucleosis Diagnostic Market Restraints in Global Market
Table 4. Key Players of Mononucleosis Diagnostic in Global Market
Table 5. Top Mononucleosis Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mononucleosis Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mononucleosis Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mononucleosis Diagnostic Product Type
Table 9. List of Global Tier 1 Mononucleosis Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mononucleosis Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Mononucleosis Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mononucleosis Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mononucleosis Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Mononucleosis Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mononucleosis Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mononucleosis Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Mononucleosis Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mononucleosis Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mononucleosis Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mononucleosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mononucleosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mononucleosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mononucleosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mononucleosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Mononucleosis Diagnostic Product Offerings
Table 32. Abbott Laboratories Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. ELITechGroup Corporate Summary
Table 34. ELITechGroup Mononucleosis Diagnostic Product Offerings
Table 35. ELITechGroup Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Beckman Coulter Corporate Summary
Table 37. Beckman Coulter Mononucleosis Diagnostic Product Offerings
Table 38. Beckman Coulter Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Laboratories Corporate Summary
Table 40. Bio-Rad Laboratories Mononucleosis Diagnostic Product Offerings
Table 41. Bio-Rad Laboratories Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Cardinal Health Corporate Summary
Table 43. Cardinal Health Mononucleosis Diagnostic Product Offerings
Table 44. Cardinal Health Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Immunostics Corporate Summary
Table 46. Immunostics Mononucleosis Diagnostic Product Offerings
Table 47. Immunostics Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Meridian Bioscience Corporate Summary
Table 49. Meridian Bioscience Mononucleosis Diagnostic Product Offerings
Table 50. Meridian Bioscience Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Quidel Corporation Corporate Summary
Table 52. Quidel Corporation Mononucleosis Diagnostic Product Offerings
Table 53. Quidel Corporation Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Sekisui Diagnostics Corporate Summary
Table 55. Sekisui Diagnostics Mononucleosis Diagnostic Product Offerings
Table 56. Sekisui Diagnostics Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Thermo Fischer Scientific Corporate Summary
Table 58. Thermo Fischer Scientific Mononucleosis Diagnostic Product Offerings
Table 59. Thermo Fischer Scientific Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Siemens Corporate Summary
Table 61. Siemens Mononucleosis Diagnostic Product Offerings
Table 62. Siemens Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 63. Biomerieux Corporate Summary
Table 64. Biomerieux Mononucleosis Diagnostic Product Offerings
Table 65. Biomerieux Mononucleosis Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Mononucleosis Diagnostic Segment by Type in 2021
Figure 2. Mononucleosis Diagnostic Segment by Application in 2021
Figure 3. Global Mononucleosis Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mononucleosis Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mononucleosis Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mononucleosis Diagnostic Revenue in 2021
Figure 8. By Type - Global Mononucleosis Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mononucleosis Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mononucleosis Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mononucleosis Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mononucleosis Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mononucleosis Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mononucleosis Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mononucleosis Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mononucleosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ELITechGroup Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Beckman Coulter Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad Laboratories Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Cardinal Health Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Immunostics Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Meridian Bioscience Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Quidel Corporation Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sekisui Diagnostics Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Thermo Fischer Scientific Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Siemens Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Biomerieux Mononucleosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)